Key Takeaways:
- Florida Medicare generally covers Spravato® (esketamine) for eligible patients when it is medically necessary to treat treatment-resistant major depressive disorder (MDD) or major depressive disorder with acute suicidal ideation or behavior, provided Medicare’s coverage criteria are met.
- Does Florida Medicare cover Spravato therapy? Yes. Original Medicare Part B typically covers Spravato because it is administered in a certified outpatient clinic, while Medicare Advantage plans also cover it but often require prior authorization and may have network-specific requirements.
- Spravato is an FDA-approved esketamine nasal spray that differs from IV ketamine therapy. Unlike IV ketamine, which is generally used off-label for depression, Spravato is FDA-approved for specific depressive disorders and is commonly eligible for Medicare coverage when medically necessary.
- To qualify for Medicare coverage, patients generally need an eligible diagnosis, documentation showing previous antidepressant treatments were unsuccessful or insufficient, and a face-to-face psychiatric evaluation supporting medical necessity.
- Spravato treatment must be provided through an FDA-required REMS (Risk Evaluation and Mitigation Strategy) program, which includes administration in a certified clinic, approximately two hours of post-treatment monitoring, and arrangements for patients to avoid driving after each session.
Florida Medicare generally covers Spravato® (esketamine) for eligible patients when it’s medically necessary. Because Spravato is taken under a provider’s supervision in a certified clinic rather than picked up at a pharmacy, it’s usually handled under Medicare Part B, and coverage depends on your diagnosis, your treatment history, and whether the paperwork supports the need for it.
What Is Spravato?
Spravato is the brand name for esketamine, a prescription medication closely related to ketamine. It’s designed for people whose depression hasn’t improved with standard antidepressants.
- It’s an FDA-approved nasal spray. You don’t swallow a pill or get an infusion; it’s sprayed into the nose, and it may begin relieving depressive symptoms more quickly than traditional antidepressants, sometimes within 24 hours for some patients
- It’s different from IV ketamine therapy. Esketamine is one specific part of the ketamine molecule, developed and studied specifically for depression and cleared by the FDA for that use.
- Originally, Spravato had to be paired with a daily oral antidepressant. As of January 2025, the Food and Drug Administration also approved it as a standalone (monotherapy) treatment for treatment-resistant depression, so many patients can now use it without another pill.
- It’s only given in certified healthcare settings. You can’t take Spravato at home. It’s administered in a clinic under supervision.
Spravato vs. Ketamine: What’s the Difference?
This is a question most people are really asking, and it matters a lot for coverage. Spravato and ketamine are related, but they’re not the same thing, and Medicare treats them very differently.
Spravato (Esketamine)
Spravato is the version that has been studied and approved by the FDA for certain depressive disorders. That FDA approval, together with Medicare’s coverage policies and medical-necessity requirements, allows many eligible patients to receive coverage. It is FDA-approved specifically for treatment-resistant depression and for depressive symptoms in MDD with acute suicidal thoughts or behavior.
- Delivered as a nasal spray.
- Comes with a required safety program (REMS).
- Given only in certified clinics under supervision.
For the right patient, Spravato is a good option for depression symptoms.
IV Ketamine
IV ketamine is the older, more familiar form, but for depression it sits in a very different regulatory spot.
- It is approved as an anesthetic, not as a depression treatment.
- Using it for depression is considered off-label.
For these reasons, it’s generally not covered by Medicare for depression, and patients typically pay out of pocket.
Does Florida Medicare Cover Spravato?
Yes. For patients who qualify, Florida Medicare covers Spravato as a medically necessary treatment for depression, though exactly how that works depends on which kind of Medicare you have.
Original Medicare (Part B)
Because Spravato is administered in a clinic by a provider, it’s billed under Medicare Part B, which covers outpatient care and provider-administered drugs. When it’s medically necessary and your documentation supports it, Part B generally covers Spravato, with you responsible for the usual outpatient service costs like your deductible and coinsurance.
Medicare Advantage (Part C)
Medicare Advantage plans have to cover at least what Original Medicare covers, so Spravato is usually covered here too. That said, there are a few things to be aware of: Prior authorization. Many Advantage plans require approval before you can begin treatment, so the clinic often has to submit documentation up front.
- Network rules. Your provider and the certified treatment center generally need to be in-network.
- Plan-specific requirements. Documentation requirements, prior authorization procedures, co-pays, and out-of-pocket costs may vary from one plan to another.
The bottom line for Advantage members is that coverage may exist, but you need to confirm the rules for your specific plan first.
Who Qualifies for Spravato Medicare Coverage?
Qualifying for Spravato coverage isn’t just about wanting to try it; Medicare looks for a specific clinical picture, backed up by documentation. There are three main criteria that must be met.
Your Diagnosis
Coverage centers on one of Spravato’s FDA-approved uses, which are:
- Treatment-resistant major depressive disorder, which is depression that hasn’t responded to other antidepressants, or
- Major depressive disorder with acute suicidal ideation or behavior, where rapid relief is a priority.
If your diagnosis lines up with one of these, you’ve cleared the first and most important hurdle for coverage.
Your Treatment History
For treatment-resistant depression, Medicare wants to see that you’ve already tried other options. That usually means a history of previous antidepressant treatment that didn’t adequately work, along with documentation showing why Spravato is the appropriate next step. In other words, your record needs to establish medical necessity, not just preference.
A Psychiatric Evaluation
Like other advanced depression treatments, Spravato has to be properly evaluated and ordered before Medicare will pay. That involves:
- A face-to-face evaluation with a qualified provider.
- A clear treatment recommendation for Spravato based on your history and diagnosis.
- Thorough documentation of all of it, since Medicare pays based on what the medical record shows.
If you meet the applicable Medicare coverage criteria, Spravato may be covered under your plan.
The REMS Program: What Makes Spravato Different
Here’s the part that sets Spravato apart from almost any other depression treatment, and it’s important to understand. Spravato comes with a Risk Evaluation and Mitigation Strategy (REMS), an FDA-required safety program. It exists because esketamine can cause temporary effects like sedation, dizziness, and dissociation (a feeling of being detached from yourself or your surroundings) in the hours right after a dose.
The REMS program is built to keep you safe while those effects pass, and it shapes what each visit looks like.
- It’s given in a certified medical office. Only clinics enrolled in the REMS program can administer Spravato; you can’t take it at home.
- You’re monitored for about two hours afterward. A healthcare team watches you until the immediate effects wear off.
- You can’t drive the rest of the day. Because of the lingering drowsiness and dissociation, you’ll need someone to drive you home and should plan to rest.
- Safety monitoring is standard. Blood pressure and your overall response are checked as part of each session.
None of this should be a deterrent; it’s just important to know. However, it does mean your appointments take longer than a typical office visit, so it’s worth planning your day and your ride home around it.
Getting Started With Spravato in Florida
If your depression hasn’t improved despite trying antidepressants and other types of treatment, Spravato may be a covered, FDA-approved option worth exploring, and Florida Medicare does cover it for patients who meet the criteria. The key is working with a certified practice that can confirm you’re a candidate, handle the documentation Medicare requires, and guide you through the REMS process safely.
Contact Luxury Psychiatry Clinic today so we can help you get started. We’ll verify your Medicare benefits and determine if you are a candidate for Spravato. Call today to schedule a consultation.
